Company: ABBV
Filing Date: 2025-02-18
Form Type: 424B5
Source: 0001104659-25-014554
Chunk: 4

Company: AbbVie Inc.
Filing Date: 2025-02-18
Form: 424B5
Chunk 4
---
 also maintains an Internet site at www.abbvie.com. AbbVie’s website and the information contained therein or connected thereto shall not be deemed to be incorporated herein, and you should not rely on any such information in making an investment decision.

AbbVie is a Delaware corporation. The address of AbbVie’s principal executive offices is 1 North Waukegan Road, North Chicago, Illinois 60064. AbbVie’s telephone number is (847) 932-7900.

<div align='center'>S-2</div>

TABLE OF CONTENTS

#### The Offering
The summary below describes the principal terms of the Notes offered hereby. Certain of the terms and conditions described below are subject to important limitations and exceptions. You should carefully review the “Description of Notes” section of this prospectus supplement, which contains a more detailed description of the terms and conditions of the Notes.

Issuer

AbbVie Inc.

Securities Offered

$ aggregate principal amount of 20 Notes.

$ aggregate principal amount of 20 Notes.

$ aggregate principal amount of 20 Notes.

$ aggregate principal amount of 20 Notes.

Interest Rate on Notes

% for the 20 Notes.

% for the 20 Notes.

% for the 20 Notes.

% for the 20 Notes.

Interest Payment Dates

and of each year, commencing , 2025.

Maturity Date

, 20 for the 20 Notes.

, 20 for the 20 Notes.

, 20 for the 20 Notes.

, 20 for the 20 Notes.

Optional Redemption

We may redeem the Notes of any series at our option, in whole or in part, at any time and from time to time at the applicable redemption price set forth under the caption “ Description of Notes — Optional Redemption .”

Ranking

The Notes will be the Issuer’s unsecured, unsubordinated obligations, and will:

•

rank equally in right of payment with all of the Issuer’s existing and future unsecured, unsubordinated indebtedness, liabilities and other obligations;

•

rank senior in right of payment to all of the Issuer’s future indebtedness that is subordinated to the Notes;

•

be effectively subordinated in right of payment to all of the Issuer’s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness; and

•

be structurally subordinated in right of payment to all existing and future indebtedness, liabilities and other obligations of the Issuer’s subsidiaries.